Skip to content

Author

Xin-Ling Yang

We have 2 of 116 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Acteoside alleviates Parkinson's disease-associated neurodegeneration and oxidative stress via an m6A-dependent Nrf2 regulatory axis.

Acteoside (ACT), a compound extracted from Cistanche tubulosa, was found to exert neuroprotective effects in dopaminergic neurons and improved the synucleinopathy in a mouse PD model, providing evidence that ACT could be a potential therapeutic agent for PD.

Ya-Tan Li, Yu-Jie Zeng, Q. Luo et al. · 0 citations
Review Open access 2026

Adoptive NK and γδT Cell Immunotherapy in Neurodegenerative Disease: Modulating Neuroinflammation and Advancing Clinical Translation

The synergistic mechanisms by which natural killer and γδT cells cross the blood-brain barrier and eliminate pathogenic proteins are discussed and the mechanisms by which these cells modulate neuroinflammation and eliminate autoreactive T cells in the central nervous system are elucidated.

Zhanghua Wu, Xiao-Lin Chen, Ting-Ting Gan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.